摘要
为探讨肝移植治疗肝脏终末期病变的方法 ,采用改良的背驮式肝移植技术即保留肝后下腔静脉的全病肝切除。将供肝植于受肝原位 ,供、受体肝上下腔静脉 ,供、受体门静脉 ,供、受体肝动脉和胆总管行对端吻合 ,结扎供肝肝下腔静脉。用FK5 0 6、晓悉和泼尼松 (下同 )三联免疫抑制剂抗排斥反应 ,加强术后监护和感染的控制。结果例 1、2目前分别存活 12、9个月余 ,生活自理 ,例 3因术后并发急性肾功能衰竭死亡 ,存活 14天。提示肝移植是治愈肝脏终末期病变的可靠方法。
Piggyback orthotopic liver transplantation was performed in three patients with terminal liver disease.After resection of the patient′s liver with preservation of the recipient inferior vena cava,the donor liver was transplanted into the patient with an end to end anastomosis of the inferior vena cava above the liver,portal vein,hepatic artery and common bile duct between the donor and the recipient liver,with the ligation of subhepatic inferior vena cava.The liver rejection was controlled by FK506,Xiaoxi and prednisone. We reinforced monitoring of the patient and infection was prevented after the operation.So far,two patients have survived and led a normal life for 12 and 9 months,respectively.The third patient died of renal failure on the postoperative 14 days.The liver transplantation is a safe and effective curative means for terminal liver disease.
出处
《解放军医学杂志》
CAS
CSCD
北大核心
2001年第5期366-368,共3页
Medical Journal of Chinese People's Liberation Army
基金
福建省科委重大科技项目资助课题!(编号 992 14 )
关键词
背驮式肝移植
肝脏终末期病变
术式
生存率
Piggyback orthotopic liver transplantation
terminal liver disease
